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Abstract
Few studies have focused on the impact of weight maintenance on cardiovascular disease risk
factors or addressed whether changes differ by baseline weight status and medication usage. The
authors examined these issues using 9 years of follow-up data on 3,235 men and women from the
Atherosclerosis Risk in Communities (ARIC) Study who were aged 45–64 years at baseline
(1987–1989). In participants not using medications, glucose (3.0 mg/dl, 95% confidence interval
(CI): 2.4, 3.5) and triglycerides (10.1 mg/dl, 95% CI: 8.3, 11.9) increased, while total cholesterol
(−9.6 mg/dl, 95% CI: −10.6, −8.6), low density lipoprotein cholesterol (−9.9 mg/dl, 95% CI:
−10.9, −9.0), and high density lipoprotein cholesterol (−1.7 mg/dl, 95% CI: −2.1, −1.3)
decreased. Systolic blood pressure (7.9 mmHg, 95% CI: 7.3, 8.4) increased, but diastolic blood
pressure (−1.1 mmHg, 95% CI: −1.4, −0.7) declined. Normal weight (body mass index: 18.5–
<25.0 kg/m2) participants had smaller increases in glucose compared with obese (body mass
index: ≥30.0 kg/m2) participants. In contrast, the authors found less favorable changes in total,
low density lipoprotein, and high density lipoprotein cholesterol, triglycerides, and diastolic blood
pressure among normal weight compared with obese participants who maintained their weight.
These patterns were similar across weight status groups regardless of medication usage.
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Many types of weight loss programs have shown some success in reducing body weight in
the short term but little success in maintaining weight loss in the long term. In recognition of
the importance of weight maintenance, investigators are now developing and testing
interventions designed specifically to promote weight maintenance (1–4). Weight
maintenance is important, not just for individuals who have lost weight, but also for adults in
general. On average, Americans gain weight throughout early and middle adulthood, and
this trend may continue through the sixth or seventh decade (5–10).
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It is reasonable to hypothesize that maintenance of an obese weight might be associated with
less favorable changes in risk factors than maintenance of a leaner weight. The presence of
excessive amounts of subcutaneous and visceral adipose tissue could drive deleterious
changes in risk. On the other hand, changes in risk factors with weight maintenance could be
more favorable in obese individuals if their risk factors had reached a threshold level beyond
which further increases over time were attenuated. Either way, the effects of weight
maintenance could differ depending on baseline weight status. We know of only one study
that has examined the influence of baseline weight on changes in risk factors among
individuals who have maintained their weight (11). That study, conducted in young adults,
did not examine changes with and without medications. Risk factor levels are less favorable
in obese than in normal weight individuals, and obese adults are more likely to be taking
medications designed to control or lower risk factors. This could complicate comparisons
among weight status groups. In addition, types and usage of medications change over time,
and responses to medications could be associated with body weight.
The primary objective of this study was to describe changes in cardiovascular disease risk
factors in individuals who maintained their weight over a 9-year interval. We also examined
whether changes in risk factors differed by baseline weight status (normal weight,
overweight, or obese) in individuals who maintained their weight. We focused separately on
individuals who did not use medications in order to estimate changes that were unaffected
by pharmaceutical interventions and also compared patterns in risk factor changes with
medications. The cardiovascular disease risk factors examined were fasting glucose;
triglycerides; total, low density lipoprotein (LDL), and high density lipoprotein (HDL)
cholesterol; and systolic and diastolic blood pressure.
MATERIALS AND METHODS
Study population
The Atherosclerosis Risk in Communities (ARIC) Study is a prospective investigation of the
natural history and etiology of atherosclerosis and cardiovascular disease. Between 1987 and
1989, population-based samples of White and African-American adults, 45–64 years of age,
were studied in four US communities: Forsyth County, North Carolina; Jackson,
Mississippi; the northwestern suburbs of Minneapolis, Minnesota; and Washington County,
Maryland. A total of 15,792 participants were included in the baseline data collection. A 9-
year follow-up visit took place between 1996 and 1998 with two intermediate visits at
approximately 3 and 6 years. The details of the study design have been described previously
(12). This study was approved by the institutional review board at each field center, and this
analysis was approved by the University of North Carolina at Chapel Hill School of Public
Health institutional review board on research involving human subjects.
Measures and covariates
Study participants were instructed to fast for 12 hours prior to their clinic visit. At each
clinic visit, blood samples were drawn and sent to the Central Clinical Chemistry Laboratory
in Minneapolis, Minnesota, for glucose determination. Serum glucose was measured by the
hexokinase/glucose-6-phosphate dehydrogense method. For lipid determinations, blood
samples were sent to the Central Lipid Laboratory in Houston, Texas, which participated in
the Centers for Disease Control and Prevention’s Lipids Standardization Program. Plasma
total cholesterol (13) and triglycerides (14) were determined by enzymatic methods. HDL
cholesterol was measured after dextran-magnesium precipitation (15). The Friedewald
method was used to calculate LDL cholesterol (16). LDL cholesterol was not calculated for
participants with triglyceride levels of ≥400 mg/dl (4.52 mmol/liter). Systolic and diastolic
blood pressure was measured three times after a 5-minute rest by use of a random zero
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sphygmomanometer on the right arm of the seated participant. The average of the last two
measures was used for the analysis.
Body weight was measured at all clinic visits in a scrub suit to the nearest pound (1 pound =
0.45 kg) by use of a beam balance scale. Height (without shoes) was measured to the nearest
centimeter using a metal rule attached to a wall and a standard triangular headboard. Body
mass index (weight (kg)/height (m)2) was categorized as normal weight (18.5–<25.0 kg/m2),
overweight (25.0–<30.0 kg/m2), or obese (≥30.0 kg/m2).
Participants were classified as weight maintainers if they met one of the two following
conditions: 1) 9-year follow-up weight was ±3.0 percent of baseline weight, or 2) baseline
and follow-up weights were ±3.0 percent of the average weight calculated for each
participant over all visits during the 9-year interval. A recent review recommended that
weight maintenance be defined as ±3.0 percent (17). Among participants who attended the
9-year examination, 99 percent had a measured weight for at least three of the four visits,
and 95 percent had weights at all four visits. Among the weight maintainers, 73.0 and 87.8
percent met the first and second definitions, respectively, and 60.8 percent met both
definitions.
To measure weight fluctuation, we calculated the root mean squared error around the
regression line of weight in relation to age for each subject, using all available measured
weights. This indicated weight fluctuation independent of the overall trend in weight.
Age (date of birth), race/ethnicity, and gender were self-reported during the recruitment
phase and confirmed during the clinic visit. Additional covariates assessed by interviewer-
administered questionnaires at baseline included education level, physical activity, and diet.
We categorized education as less than a high school education, high school graduate, or at
least some college. Physical activity was assessed with the Baecke leisure time physical
activity questionnaire (18) and categorized using tertiles. A 66-item, semi-quantitative food
frequency questionnaire was used to assess diet (19). The specific aspects of diet examined
included total energy, total dietary fat, saturated fat, dietary cholesterol, and dietary fiber and
the percentage of calories from total dietary fat.
At each visit, participants self-reported their cigarette smoking status and alcoholic beverage
consumption and were categorized as current, former, or never cigarette smokers and as
current, former, seldom/rare, or never alcoholic beverage consumers. In addition,
participants self-reported taking medications for high blood pressure or diabetes or high
blood sugar in the past 2 weeks. They were asked to bring all medications taken during this
period to the clinic examination, and the names of all medications were transcribed, coded,
and then mapped to Medi-Span Therapeutic Classification codes and American Hospital
Formulary Service Classification Compilation codes. The former codes for vitamin B3 and
antihyperlipidemic and bile sequestrants or the latter code for antilipemic agents was coded
for lipid-lowering medications.
Samples for analyses
It is standard ARIC protocol to exclude African Americans from the Washington County,
Maryland, or Minneapolis, Minnesota, centers (n = 55), as well as participants who
classified their ethnicity as other than White or African American (n = 48), because they
were too small in number to allow ethnic- and center-specific analyses. In addition, we
excluded participants who met one of the following conditions: 1) died prior to visit 4 (n =
1,441); 2) did not attend the 9-year examination (n = 2,661); 3) had missing baseline (n =
20) or 9-year follow-up (n = 34) weight; 4) was underweight at baseline (n = 78); 5) had
diabetes, stroke, cancer, or heart disease at baseline (n = 2,029); 6) had unknown prevalent
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disease status at baseline (n = 443); 7) reported fasting less than 8 hours at baseline (n =
159) or follow-up (n = 209); 8) had missing any outcome variable at baseline (n = 184) or
follow-up (n = 145); 9) had missing pertinent covariates (n = 101); or 10) did not meet
weight maintenance criteria (n = 4,950). The final analysis data set included 1,147 normal
weight, 1,333 overweight, and 755 obese White and African-American men and women.
Statistical analysis
Mean values, standard deviations, and percentages were used to describe weight maintainers
overall and to compare across baseline weight status categories. All four race-gender groups
were combined for these analyses, as we found no significant interactions of gender or race
with weight change. Because not all four field sites included Whites and African-American
participants, we created a race-center variable (five levels). Generalized linear models
adjusted for age, education, and race-center were used to estimate and compare the mean
level of each cardiovascular disease risk factor at baseline and follow-up.
A priori variables for inclusion in the multivariable linear regression models included race-
center, gender, age, education level, and interval length. The final full models also included
baseline smoking status, baseline alcoholic beverage consumption status, absolute weight
change, weight fluctuation, and medication usage at baseline or follow-up (when
applicable). We examined analyses that adjusted for self-reported physical activity, dietary
cholesterol, total fat, saturated fat, dietary fiber, and energy intake at baseline and alcohol
consumption and smoking status at follow-up. None of these adjustments changed our mean
estimates by an amount as large as 3 percent of one standard deviation. The LSMEANS
option was used with the PROC GENMOD procedure (SAS Institute, Inc., Cary, North
Carolina) to estimate the adjusted mean 9-year change and 95 percent confidence interval
for each outcome by baseline weight status group and to determine if there were significant
differences (p < 0.05) in the magnitude and direction of the changes between groups. Similar
analyses were conducted after stratifying weight maintainers by medication usage. For lipids
and blood pressure, individuals on medication were also stratified into three mutually
exclusive groups (follow-up only; baseline only; or baseline and follow-up). Data were
analyzed using SAS, version 9.1, software (SAS Institute, Inc.).
RESULTS
Among all ARIC participants with 9 years of follow-up data, 39.3 percent met our criteria
for weight maintenance, whereas 39.5 percent of the participants who met our other
inclusion criteria maintained their weight. Characteristics of the sample for analysis are
shown in table 1. At baseline, 35 percent of weight maintainers were normal weight, 41
percent were overweight, and 23 percent were obese. This is similar to the baseline weight
status distribution in the entire ARIC cohort: 32 percent, 39 percent, and 28 percent,
respectively. Given that our definition of weight maintenance was based on a percentage
change in weight, it was expected that the absolute amount of weight change would be
smallest among normal weight participants, intermediate among overweight participants,
and largest among obese participants. The differences were small, and however expressed,
the mean changes were near zero. The mean weight fluctuation, as measured by the root
mean squared error, was larger in heavier participants. Overall, the root mean squared error
was correlated with baseline body mass index (r = 0.26), indicating that participants who
were heavier at baseline had greater weight fluctuations. There were few changes in
smoking status over the 9-year interval, although the percentage of former smokers tended
to increase. Obese participants were less likely to consume alcohol and were less physically
active. Total energy and total and saturated fat intake were significantly different by weight
status, with overweight participants having the highest intake. The percentages of calories
from fat and dietary cholesterol intake were slightly lower in normal weight participants
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compared with overweight and obese participants. Overweight and obese participants were
more likely than normal weight participants to be taking diabetes, lipid-lowering, and
antihypertensive medications at follow-up.
Table 2 shows the age-, gender-, race-, and field site-adjusted means for the seven risk
factors at baseline and at the 9-year follow-up. At baseline, the risk factor levels were most
favorable in normal weight participants and least favorable in obese participants, with
overweight participants intermediate. At follow-up, total and LDL cholesterol did not follow
this trend, and the estimate was highest among overweight participants, although differences
were not statistically significant.
The fully adjusted 9-year mean changes in glucose and lipids are shown in figure 1. When
examining baseline body mass index (continuous), we found significant linear associations
with 9-year change in glucose, systolic blood pressure, diastolic blood pressure, and
triglycerides. We found a quadratic association between baseline body mass index and 9-
year changes in total and LDL cholesterol. There was no significant association between
baseline body mass index and 9-year changes in HDL cholesterol. In general, there were
unfavorable changes over time in glucose, HDL cholesterol, and triglycerides but favorable
changes in total and LDL cholesterol. When comparing body mass index categories (weight
status), we found that normal weight maintainers had smaller increases in glucose (2.2 mg/
dl) compared with overweight (3.8 mg/dl) and obese (8.6 mg/dl) weight maintainers. In
contrast, for all lipid parameters measured, changes tended to be least favorable in normal
weight participants and most favorable in obese participants.
Similar analyses are shown for systolic and diastolic blood pressure in figure 2. Over the
study period, there were increases in systolic blood pressure but decreases in diastolic blood
pressure. There were no significant differences in 9-year changes in systolic blood pressure
by baseline weight status. However, normal weight maintainers had less favorable changes
(−1.6 mmHg) in diastolic blood pressure compared with overweight (−2.5 mmHg) and
obese (−3.4 mmHg) weight maintainers.
We examined the two-way interactions between medications and weight status for all the
changes in risk factors. It was significant only for glucose (p < 0.0001) and appeared to be
driven by the difference in the relative sizes of the changes in normal weight compared with
overweight maintainers in the medication usage categories. Table 3 illustrates that
medications had large effects on the 9-year changes in lipids and blood pressure in the
expected directions. For glucose, being on a glucose-lowering medication was a marker for
diabetes, and the participants who developed diabetes over the follow-up had larger
increases in glucose levels, despite taking medications. Overall, in participants who did not
take medications at baseline or follow-up and maintained their weight, fasting glucose,
triglycerides, and systolic blood pressure increased. HDL cholesterol also became less
favorable (declined). However, total cholesterol, LDL cholesterol, and diastolic blood
pressure became more favorable over the 9-year period (declined). The direction of trends in
changes in risk factors among weight status groups was generally the same regardless of
medication usage. There were some exceptions in categories with small sample sizes.
Overall, glucose, triglycerides, and systolic blood pressure increased among weight
maintainers not on glucose, lipid-lowering, or antihypertensive medications, respectively.
HDL cholesterol decreased among weight maintainers not on lipid-lowering medications. In
contrast, total and LDL cholesterol improved significantly among weight maintainers not on
lipid-lowering medications. The magnitude of the 9-year changes in glucose, lipids, and
blood pressure was attenuated when examining weight maintainers not on medication and
with normal levels for the respective risk factor. We found no significant differences
between normal weight and obese subjects, with two exceptions. Obese nondiabetic weight
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maintainers had more adverse changes in glucose than did normal weight nondiabetic
weight maintainers. However, obese normotensive weight maintainers had more favorable
changes in diastolic blood pressure than did normal weight normotensive weight
maintainers.
DISCUSSION
Although weight maintenance literally implies no change in body weight, in free-living
individuals, weight varies over time, even when fat stores are relatively constant. In practice,
researchers must define a range of weight change to be called weight maintenance. Recently,
we reviewed studies that examined weight change and included a category identified as
“weight maintenance” (17). We found that there was little consensus among investigators in
the definition of weight maintenance. Many definitions have been used, including ±5.0
percent (20–25), ±2.5 kg (26–33), and ±5.0 kg (5, 34–38). We have recommended that
weight maintenance be defined as ±3.0 percent (17). These bounds were chosen as
adequately large to avoid differences due to measurement error and normal fluid balance.
Using the ±3.0 percent weight maintenance definition, we have shown that a substantial
number, albeit a minority, of adults from four communities in the United States maintained
their weight over a 9-year period. Their waist circumference increased by 3.3–4.4 cm during
this period. This is consistent with the research by Forbes (39), showing that even with
weight maintenance, adults lose about 1.5 kg of fat-free mass per decade. With 9 years of
aging, glucose, triglycerides, and systolic blood pressure increased. Also, HDL cholesterol
became less favorable. In contrast, total cholesterol, LDL cholesterol, and diastolic blood
pressure all declined, even in participants who were not taking medications. The direction of
change among those who were not taking medications was the same regardless of baseline
weight status, and changes in risk factors were equally or more favorable in obese compared
with normal weight individuals for all the risk factors studied, with the exception of fasting
glucose. Trends among weight status groups were generally the same, regardless of whether
subjects were taking medications to control their risk factor levels.
There have been systematic secular trends in cardiovascular disease risk factors over the last
four decades. Gregg et al. (40) recently showed that, among lean adults (body mass index:
<25 kg/m2), the prevalence of hypercholesterolemia (≥240 mg/dl) declined by 11.9
percentage points (95 percent CI: 8.1, 15.7) between national surveys conducted in 1960–
1962 and 1999–2000. The prevalence of high blood pressure (systolic blood pressure: ≥140
mmHg, or diastolic blood pressure: ≥90 mmHg) declined over the same period from 24.8
percent to 10.5 percent. In contrast, the prevalence of diabetes did not change significantly
over time, with diagnosed diabetes tending to increase from 1.5 percent to 2.8 percent
among lean individuals over the span of approximately four decades.
Comparisons of results from the cross-sectional National Health and Nutrition Examination
Survey over time allow an assessment of secular trends, while in longitudinal studies,
secular trends are superimposed upon the effects of aging. Nevertheless, it is informative to
observe changes over time in the same individuals, and the ARIC Study and the Coronary
Artery Risk Development in Young Adults (CARDIA) Study are two longitudinal studies
that can provide insights into changes in risk factors in the United States over the past two
decades. An analysis of 3-year changes between the first two examinations of the ARIC
cohort showed that total cholesterol and the prevalence of hypercholesterolemia declined
(41). Among participants who did not take cholesterol-lowering medications, the change
was −4.3 mg/dl, despite increases in body mass index over the entire cohort that averaged
1.2 kg/m2.
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During this 9-year time frame, the usage of statins and other lipid-lowering medications
changed considerably. In the present study, less than 2 percent of weight maintainers were
on lipid-lowering medications at baseline. This increased to approximately 11.2 percent 9
years later. The differential usage of lipid-lowering medications could bias our findings.
However, when we examined participants not on lipid-lowering medications with normal
cholesterol levels (total cholesterol: <200 mg/dl), we found significant decreases in total and
LDL cholesterol, thus suggesting that the improvements found in total and LDL cholesterol
among weight maintainers were not due to pharmacotherapy treatment.
Another potential limitation of this study is that approximately one fourth of the ARIC
participants died prior to or did not attend the 9-year clinic visit. However, we found similar
mean changes in risk factors over 3 and 6 years when comparing the excluded individuals
who maintained their weight with our analysis sample (data not shown).
Norman et al. (42) showed that, in CARDIA Study participants who lost weight (≤0 kg),
LDL cholesterol declined over a 10-year period starting in 1985–1986. The mean weight
change in this group ranged from −5.9 to −2.0 kg in different gender and ethnic groups. Our
analysis of 15-year changes in the CARDIA Study data (11), using the same definition of
weight maintenance used here, also showed that LDL cholesterol levels declined in
participants who maintained their weight. Thus, the results shown here from the ARIC Study
are consistent with evidence from the National Health and Nutrition Examination Survey
(40), the CARDIA Study (11), and previous work in the ARIC Study (41) showing declines
in LDL cholesterol over the past two decades.
Similar to our findings in the ARIC Study, CARDIA Study participants who maintained
their weight had increases in triglyceride levels over the follow-up period (11, 42). The
direction of the changes in glucose, HDL cholesterol, and blood pressure varied among the
groups in the CARDIA Study, and these were not always consistent with the ARIC Study
results. Changes in risk factors may have differed because the CARDIA Study cohort was
younger (18–30 years at baseline) than the ARIC Study cohort (45–64 years at baseline),
and the number of weight maintainers in the CARDIA Study (n = 488) was much smaller
than the group from the ARIC Study reported on here (n = 3,235).
In the ARIC Study cohort, obese adults who maintained their weight had long-term changes
in risk factors that were the same or more favorable than changes in normal weight adults
for lipid levels and blood pressure. This finding was not due to differences in the use of
medications. Nevertheless, it is important to keep in mind that the absolute levels of
cardiovascular disease risk factors were less favorable among obese compared with normal
weight subjects. In the ARIC Study cohort, higher body mass index levels at baseline were
associated with less favorable levels of glucose, LDL cholesterol, HDL cholesterol,
triglycerides, and systolic and diastolic blood pressure. In addition, weight gain over a 9-
year period was associated with unfavorable changes in all the same risk factors (data not
shown). This is consistent with several other studies that have shown that cardiovascular risk
factors improve with weight loss and become less favorable with excess weight gain (43–
46).
We intentionally focused the current work on weight maintenance rather than weight
change, because weight maintenance has not been as well studied. This is a special
subpopulation and may limit the generalizability of the present study, because most
Americans gain weight as they pass from early to late adulthood (5–10). For some
individuals, weight maintenance may be a more attainable goal than weight loss, and careful
examination of weight maintenance is merited. Although the public health message remains
that obesity and excess weight gain should be avoided in order to reduce cardiovascular risk,
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it is useful to know that changes in cardiovascular disease risk factors are not necessarily
more favorable in normal weight compared with obese adults who maintain their weight.
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Nine-year mean changes and 95% confidence intervals in glucose and lipids among adult
weight maintainers by baseline weight status, the Atherosclerosis Risk in Communities
Study, 1987–1998. Refer to the Materials and Methods section for the adjustment factors.
For glucose, significant differences (p < 0.05) were observed between normal weight
maintainers and overweight or obese weight maintainers and between overweight
maintainers and obese maintainers. For total and low density lipoprotein cholesterol,
significant differences were observed between normal weight maintainers and overweight or
obese weight maintainers. For high density lipoprotein cholesterol and triglycerides, a
significant difference was observed between normal weight maintainers and obese
maintainers only.
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Nine-year mean changes and 95% confidence intervals in systolic and diastolic blood
pressure among adult weight maintainers by baseline weight status, the Atherosclerosis Risk
in Communities Study, 1987–1998. Refer to the Materials and Methods section for the
adjustment factors. For diastolic blood pressure, significant differences (p < 0.05) were
observed between normal weight maintainers and overweight or obese weight maintainers.
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TABLE 1
Demographic characteristics among weight maintainers by baseline weight status, the Atherosclerosis Risk in
Communities Study, 1987–1998
Overall (n = 3,235)
Baseline weight status
Normal weight (n =
1,147) Overweight (n = 1,333) Obese (n = 755)
Ethnicity (% White) 80.7 89.5 81.5* 66.1†
Gender (% male) 50.9 41.1 64.5* 42.0‡
Age at baseline (years, mean (SD§)) 54.2 (5.6) 54.3 (5.6) 54.5 (5.6) 53.6 (5.6)†
Body mass index at baseline (kg/m2, mean
(SD))
27.2 (5.0) 22.7 (1.6) 27.2 (1.4)* 34.1 (4.4)†
9-year weight change (kg, mean (SD)) 0.6 (2.0) 0.5 (1.6) 0.7 (1.9)* 0.7 (2.5)*
9-year weight change (%, mean (SD)) 0.8 (2.5) 0.8 (2.5) 0.9 (2.4) 0.7 (2.6)
Weight fluctuation (RMSE,§ mean (SD)) 4.2 (3.6) 3.2 (2.5) 4.2 (3.0)* 5.7 (5.1)†
Education level (%)
 Less than high school education 17.2 11.5 17.9* 25.0†
 High school graduate 41.4 42.4 41.1 40.3
 Some college or more 41.4 46.1 41.0 34.7
Cigarette smoking status at baseline (%)
 Current 46.9 48.6 41.8 53.3†
 Former 35.8 30.5 41.6 33.5
 Never 17.3 20.9 16.6 13.2
Cigarette smoking status at follow-up (%)
 Current 43.0 44.1 38.0 50.1†
 Former 43.6 38.8 49.4 40.4
 Never 13.4 17.1 12.6 9.4
Physical activity tertiles at baseline (%)
 Low 25.21 20.9 23.6 34.5†
 Middle 42.8 42.7 41.8 44.6
 High 32.1 36.4 34.6 20.9
Alcoholic beverage consumption status at baseline (%)
 Current 43.5 44.5 48.8* 32.6†
 Former 14.4 12.1 14.6 17.6
 Seldom/rare 18.6 21.3 16.7 18.2
 Never 23.5 22.1 20.0 31.7
Alcoholic beverage consumption status at follow-up (%)
 Current 35.5 39.2 39.9 22.1†
 Former 27.1 23.3 27.8 31.4
 Seldom/rare 17.4 18.9 15.3 19.0
 Never 20.0 18.6 17.0 27.5
Total energy intake at baseline (kcal, mean
(SD))
1,654.9 (595.3) 1,590.0 (564.1) 1,713.7 (617.6)* 1,649.2 (591.7)†
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Overall (n = 3,235)
Baseline weight status
Normal weight (n =
1,147) Overweight (n = 1,333) Obese (n = 755)
Total dietary fat at baseline (g, mean (SD)) 61.2 (26.2) 57.9 (25.3) 64.2 (27.3)* 61.2 (25.0)†
Saturated fat at baseline (g, mean (SD)) 22.5 (10.4) 21.2 (9.9) 23.6 (10.9)* 22.4 (9.9)†
Dietary cholesterol at baseline (mg, mean
(SD))
244.9 (121.5) 228.0 (118.0) 254.7 (125.6)* 253.1 (116.7)*
Dietary fiber at baseline (g, mean (SD)) 17.4 (7.9) 17.5 (7.9) 17.5 (7.8) 17.2 (8.1)
% of calories from total dietary fat at
baseline (mean (SD))
33.1 (6.4) 32.4 (6.6) 33.5 (6.3)* 33.3 (6.1)*
Diabetes medications at follow-up (%) 2.7 0.6 1.7* 7.7†
Lipid-lowering medications (%)
 At baseline or follow-up 12.3 10.4 13.2* 13.7*
 At baseline only 0.7 0.9 0.4 0.8
 At follow-up only 10.5 8.4 11.8* 11.5*
 At baseline and follow-up 1.0 1.1 0.9 1.2
Antihypertensive medications (%)
 At baseline or follow-up 32.4 20.8 32.0* 50.9†
 At baseline only 1.6 1.2 1.4 2.5*
 At follow-up only 13.6 10.6 13.4* 18.8†
 At baseline and follow-up 17.2 9.0 17.3* 29.5†
*
Significantly different (p < 0.05) from normal weight maintainers.
†
Significantly different (p < 0.05) from normal weight and overweight weight maintainers.
‡
Significantly different (p < 0.05) from overweight weight maintainers only.
§
SD, standard deviation; RMSE, root mean squared error.
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